<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated, to examine the involvement of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and inhibitory mechanisms, a novel <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation inhibitor (KB-5666) and a GABAA receptor-effector (<z:chebi fb="0" ids="7983">pentobarbital</z:chebi>) on ischemic neuronal damage and the alterations in the second messenger and neurotransmitter systems in Mongolian gerbils by means of <z:mp ids='MP_0000002'>morphology</z:mp> and in vitro receptor autoradiography </plain></SENT>
<SENT sid="1" pm="."><plain>Quantitative receptor autoradiography visualized binding sites for [3H]<z:chebi fb="1" ids="24848">inositol</z:chebi> 1,4,5-trisphosphate, [3H]<z:chebi fb="0" ids="42471">forskolin</z:chebi>, [3H]<z:chebi fb="0" ids="17598">phorbol 12,13-dibutyrate</z:chebi>, [3H]isradipine (PN200-110), [3H]N6-<z:chebi fb="0" ids="52552">cyclohexyl</z:chebi>-<z:chebi fb="3" ids="16335">adenosine</z:chebi>, and [3H]quinuclidinyl benzilate indicating binding sites for <z:chebi fb="1" ids="24848">inositol</z:chebi> 1,4,5-trisphosphate, <z:chebi fb="0" ids="42471">forskolin</z:chebi>, protein kinase C, L-type calcium channels (or <z:chebi fb="0" ids="50075">dihydropyridine</z:chebi> binding sites), <z:chebi fb="3" ids="16335">adenosine</z:chebi> A1, and muscarinic cholinergic receptors, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>In the morphological study, KB-5666, 10 and 50 mg/kg, i.v., 5 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, protected against ischemic neuronal damage to the hippocampal CA1 subfield following 5 min of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> in a dose-dependent manner </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="7983">Pentobarbital</z:chebi>, 30 mg/kg, i.v., 5 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, also had a protective effect </plain></SENT>
<SENT sid="4" pm="."><plain>In receptor autoradiographic studies, <z:hpo ids='HP_0000001'>all</z:hpo> receptor bindings decreased significantly in the CA1 subfield seven days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In particular, [3H]<z:chebi fb="1" ids="24848">inositol</z:chebi> 1,4,5-trisphosphate binding in the CA1 subfield was completely lost after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>[3H]<z:chebi fb="1" ids="24848">Inositol</z:chebi> 1,4,5-trisphosphate and [3H]<z:chebi fb="0" ids="42471">forskolin</z:chebi> binding decreased as early as 6 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In the CA3 subfield, [3H]<z:chebi fb="1" ids="24848">inositol</z:chebi> 1,4,5-trisphosphate, [3H]PN200-110, and [3H]N6-cyclohexyladenosine bindings decreased seven days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In the dentate gyrus, [3H]<z:chebi fb="1" ids="24848">inositol</z:chebi> 1,4,5-trisphosphate binding decreased seven days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>KB-5666 and <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> prevented reductions in these receptor bindings in the CA1 subfield at 6 h and seven days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>These results indicate that KB-5666 and <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> protect the brain from both structural and functional damage after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and that <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and inhibitory mechanisms may play a pivotal role in the neuronal damage of the hippocampal CA1 subfield after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>